{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:57:51Z","timestamp":1787795871722,"version":"build-2784847793"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005565","name":"Johnson & Johnson Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gtc.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T07:43:20Z","timestamp":1733298200000},"page":"333-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Beyond Random Fecal Microbial Transplants"],"prefix":"10.1016","volume":"54","author":[{"given":"R. Balfour","family":"Sartor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gtc.2024.11.002_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.chom.2024.07.023","article-title":"Microbiome modification for personalized treatment of dysbiotic diseases","volume":"32","author":"Sartor","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan","year":"2022","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1053\/j.gastro.2020.09.056","article-title":"Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues","volume":"160","author":"Lee","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2023.09.019","article-title":"Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care","volume":"166","author":"Gilliland","year":"2024","journal-title":"Gastroenterology"},{"issue":"7758","key":"10.1016\/j.gtc.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gtc.2024.11.002_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.gtc.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41588-022-01156-2","article-title":"Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility","volume":"54","author":"Sazonovs","year":"2022","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","article-title":"High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease","volume":"127","author":"Darfeuille-Michaud","year":"2004","journal-title":"Gastroenterology"},{"issue":"34","key":"10.1016\/j.gtc.2024.11.002_bib11","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6361","key":"10.1016\/j.gtc.2024.11.002_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.aan4526","article-title":"Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation","volume":"358","author":"Atarashi","year":"2017","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.gtc.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.gtc.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ibd\/izy386","article-title":"Murine adherent and invasive E. coli induces chronic inflammation and immune responses in the small and large intestines of monoassociated IL-10-\/- mice independent of long polar fimbriae adhesin A","volume":"25","author":"Schmitz","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"23","key":"10.1016\/j.gtc.2024.11.002_bib15","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.3390\/ijms242317124","article-title":"Role of mitochondria in inflammatory bowel diseases: a systematic review","volume":"24","author":"Sanchez-Quintero","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chom.2016.03.004","article-title":"Depletion of butyrate-producing clostridia from the gut microbiota drives an aerobic luminal expansion of Salmonella","volume":"19","author":"Rivera-Chavez","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.gtc.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"e157013","DOI":"10.1172\/jci.insight.157013","article-title":"Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn's disease","volume":"7","author":"Zhang","year":"2022","journal-title":"JCI Insight"},{"issue":"6120","key":"10.1016\/j.gtc.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1232467","article-title":"Host-derived nitrate boosts growth of E. coli in the inflamed gut","volume":"339","author":"Winter","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.gtc.2024.11.002_bib19","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1128\/IAI.01513-13","article-title":"Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-\/- mice","volume":"82","author":"Eun","year":"2014","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40168-024-01857-2","article-title":"Mouse adaptation of human inflammatory bowel diseases microbiota enhances colonization efficiency and alters microbiome aggressiveness depending on the recipient colonic inflammatory environment","volume":"12","author":"Gray","year":"2024","journal-title":"Microbiome"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","article-title":"Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria","volume":"128","author":"Kim","year":"2005","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcmgh.2016.02.003","article-title":"Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice","volume":"2","author":"Nagao-Kitamoto","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7461","key":"10.1016\/j.gtc.2024.11.002_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"issue":"7195","key":"10.1016\/j.gtc.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nature07008","article-title":"A\u00a0microbial symbiosis factor prevents intestinal inflammatory disease","volume":"453","author":"Mazmanian","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/s41467-021-23460-x","article-title":"Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis","volume":"12","author":"van der Lelie","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gtc.2024.11.002_bib26","article-title":"Bacterial functional interactions: H2S promotes functional interactions between mucolytic R. gnavus and adherent\/invasive E. coli LF82 relevant to intestinal inflammation","author":"Kashiwagi","year":"2023","journal-title":"Digestive Disease Week"},{"key":"10.1016\/j.gtc.2024.11.002_bib27","series-title":"Experimental colitis","article-title":"IL-10-Independent protective activities of human-derived Clostridium strains","author":"Oka","year":"2018"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41564-023-01337-7","article-title":"Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut","volume":"8","author":"Foley","year":"2023","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","article-title":"The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity","volume":"49","author":"Metidji","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.gtc.2024.11.002_bib30","doi-asserted-by":"crossref","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front Immunol"},{"issue":"4\u20136","key":"10.1016\/j.gtc.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/ars.2021.0004","article-title":"Effects of hydrogen sulfide on the microbiome: from toxicity to therapy","volume":"36","author":"Buret","year":"2022","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-022-00685-9","article-title":"Antibiotics in the pathogenesis of diabetes and inflammatory diseases of the gastrointestinal tract","volume":"20","author":"Fenneman","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.gtc.2024.11.002_bib33","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1136\/gutjnl-2023-329948","article-title":"The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease","volume":"72","author":"Lopetuso","year":"2023","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.gtc.2024.11.002_bib34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2024.11.002_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/ibd\/izy398","article-title":"Microbial engraftment and efficacy of fecal microbiota transplant for Clostridium difficile in patients with and without inflammatory bowel disease","volume":"25","author":"Hirten","year":"2019","journal-title":"Inflamm Bowel Dis"},{"issue":"24","key":"10.1016\/j.gtc.2024.11.002_bib37","first-page":"00492","article-title":"Rigorous donor selection for fecal microbiota transplantation in active ulcerative colitis: key lessons from a randomized controlled trial halted for futility","volume":"S1542-3565","author":"Caenepeel","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.gastro.2020.07.048","article-title":"A\u00a0phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis","volume":"160","author":"Henn","year":"2021","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2024.11.002_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2023.11.303","article-title":"AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review","volume":"166","author":"Hashash","year":"2024","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.gastro.2019.04.021","article-title":"Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial","volume":"157","author":"Levine","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/ecco-jcc\/jjac105","article-title":"Successful dietary therapy in paediatric crohn's disease is associated with shifts in bacterial dysbiosis and inflammatory metabotype towards healthy controls","volume":"17","author":"Verburgt","year":"2023","journal-title":"J\u00a0Crohns Colitis"},{"issue":"24","key":"10.1016\/j.gtc.2024.11.002_bib42","first-page":"00359","article-title":"Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease","volume":"S1931-3128","author":"Hacker","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.gtc.2024.11.002_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/j.gastro.2021.05.047","article-title":"A\u00a0randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with crohn's disease","volume":"161","author":"Lewis","year":"2021","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gtc.2024.11.002_bib44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","article-title":"A\u00a0dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility","volume":"167","author":"Desai","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib45","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/j.gastro.2017.11.030","article-title":"Interactions between diet and the intestinal microbiota alter intestinal permeability and colitis severity in mice","volume":"154","author":"Llewellyn","year":"2018","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.gtc.2024.11.002_bib46","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","article-title":"Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant","volume":"381","author":"DeFilipp","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2024.11.002_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"issue":"Suppl 6","key":"10.1016\/j.gtc.2024.11.002_bib48","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1093\/cid\/ciad642","article-title":"Review article: safety of live biotherapeutic products used for the prevention of Clostridioides difficile infection recurrence","volume":"77","author":"Gonzales-Luna","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gtc.2024.11.002_bib49","article-title":"Safety and Efficacy of MH002, an optimized live biotherapeutic product, for the treatment of mild to moderate ulcerative colitis: a first-in-disease double-blind, randomied clinical trial","author":"Vermeire","year":"2024","journal-title":"Digestive Disease Week abstract"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib50","first-page":"i195","article-title":"MB310: from clinical FMT to a phase 1 study with a defined, orally administered live bacterial therapeutic for mild moderate ulcerative colitis","volume":"18","author":"Villemin","year":"2024","journal-title":"J\u00a0Crohns Colitis"},{"issue":"7783","key":"10.1016\/j.gtc.2024.11.002_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12941-021-00433-y","article-title":"Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review","volume":"20","author":"Chegini","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"10.1016\/j.gtc.2024.11.002_bib53","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1172\/JCI30504","article-title":"CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease","volume":"117","author":"Barnich","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.gtc.2024.11.002_bib54","unstructured":"Simpson K. Akylboronic acids C2 to C7 inhibit the growth and virulence of adherent invasive E. coli linked to Crohn's disease. Paper presented at: Digestive Disease Week, 2023; Chicago, IL."},{"key":"10.1016\/j.gtc.2024.11.002_bib55","article-title":"Enhanced mucosal mitochondrial function corrects dysbiosis and OXPHOS metabolism in IBD","author":"Kapur","year":"2024","journal-title":"bioRxiv [Preprint]"},{"issue":"4","key":"10.1016\/j.gtc.2024.11.002_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","volume":"72","author":"Awoniyi","year":"2023","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HEP.0000000000000529","article-title":"Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: to what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?","volume":"79","author":"Corpechot","year":"2024","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.gtc.2024.11.002_bib58","doi-asserted-by":"crossref","first-page":"100711","DOI":"10.1016\/j.xcrm.2022.100711","article-title":"Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics","volume":"3","author":"Podlesny","year":"2022","journal-title":"Cell Rep Med"},{"issue":"10","key":"10.1016\/j.gtc.2024.11.002_bib59","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41564-021-00966-0","article-title":"Precise quantification of bacterial strains after fecal microbiota transplantation delineates long-term engraftment and explains outcomes","volume":"6","author":"Aggarwala","year":"2021","journal-title":"Nat Microbiol"},{"issue":"9","key":"10.1016\/j.gtc.2024.11.002_bib60","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41591-022-01964-3","article-title":"Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases","volume":"28","author":"Ianiro","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib61","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"issue":"2022","key":"10.1016\/j.gtc.2024.11.002_bib62","first-page":"327742","article-title":"Microbial determinants of effective donors in faecal microbiota transplantation for UC","volume":"gutjnl","author":"Haifer","year":"2022","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.gtc.2024.11.002_bib63","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/nu15153340","article-title":"The underlying changes in serum metabolic profiles and efficacy prediction in patients with extensive ulcerative colitis undergoing fecal microbiota transplantation","volume":"15","author":"Wu","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib64","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41467-024-46983-5","article-title":"Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice","volume":"15","author":"Luu","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.gtc.2024.11.002_bib65","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1053\/j.gastro.2020.08.045","article-title":"Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in crohn's disease","volume":"159","author":"Kong","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.11.002_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03280-4","article-title":"Noninvasive, microbiome-based diagnosis of inflammatory bowel disease","author":"Zheng","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/gmic.27129","article-title":"Dysbiosis in the inflamed intestine: chance favors the prepared microbe","volume":"5","author":"Winter","year":"2014","journal-title":"Gut Microb"},{"issue":"1","key":"10.1016\/j.gtc.2024.11.002_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1053\/j.gastro.2020.03.039","article-title":"Deep remission at 1 Year prevents progression of early crohn's disease","volume":"159","author":"Ungaro","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855324000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855324000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:41:55Z","timestamp":1762314115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855324000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0889855324000876"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2024.11.002","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Random Fecal Microbial Transplants","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}